Zobrazeno 1 - 10
of 4 433
pro vyhledávání: '"Tolmachev, V."'
Autor:
Tolmachev, V. A.1 (AUTHOR) tva@mail.ioffe.ru, Zharova, Yu. A.1 (AUTHOR), Ermina, A. A.1 (AUTHOR), Bolshakov, V. O.1 (AUTHOR)
Publikováno v:
Optics & Spectroscopy. Jan2023, Vol. 131 Issue 1, p48-53. 6p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liu Y; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 85, Sweden., Oroujeni M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 85, Sweden.; Affibody AB, Solna, 171 65, Sweden., Liao Y; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 85, Sweden., Vorobyeva A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 85, Sweden., Bodenko V; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 85, Sweden., Orlova A; Department of Medicinal Chemistry, Uppsala University, Uppsala, 751 23, Sweden., Konijnenberg M; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Carlqvist M; Affibody AB, Solna, 171 65, Sweden., Wahlberg E; Affibody AB, Solna, 171 65, Sweden., Loftenius A; Affibody AB, Solna, 171 65, Sweden., Frejd FY; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 85, Sweden.; Affibody AB, Solna, 171 65, Sweden., Tolmachev V; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 85, Sweden. vladimir.tolmachev@igp.uu.se.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Nov; Vol. 51 (13), pp. 4038-4048. Date of Electronic Publication: 2024 Jul 15.
Autor:
Konshina AG; Shemyakin & Ovchinnikov KT, Russian Academy of Sciences, Moscow 117997, Russia., Bocharov EV; Shemyakin & Ovchinnikov KT, Russian Academy of Sciences, Moscow 117997, Russia.; Moscow Center for Advanced Studies, Moscow 123592, Russia., Konovalova EV; Shemyakin & Ovchinnikov KT, Russian Academy of Sciences, Moscow 117997, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia., Schulga AA; Shemyakin & Ovchinnikov KT, Russian Academy of Sciences, Moscow 117997, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia., Tolmachev V; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden., Deyev SM; Shemyakin & Ovchinnikov KT, Russian Academy of Sciences, Moscow 117997, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia.; Laboratory of Molecular Pharmacology, Institute of Molecular Theranostics, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia., Efremov RG; Shemyakin & Ovchinnikov KT, Russian Academy of Sciences, Moscow 117997, Russia.; Moscow Center for Advanced Studies, Moscow 123592, Russia.; Department of Applied Mathematics, National Research University Higher School of Economics, Moscow 101000, Russia.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Oct 22; Vol. 25 (21). Date of Electronic Publication: 2024 Oct 22.
Autor:
Nagy Á; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, AlbaNova University Center, 106 91 Stockholm, Sweden., Abouzayed A; Department of Medicinal Chemistry, Uppsala University, 752 37 Uppsala, Sweden., Kanellopoulos P; Department of Medicinal Chemistry, Uppsala University, 752 37 Uppsala, Sweden., Landmark F; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, AlbaNova University Center, 106 91 Stockholm, Sweden., Bezverkhniaia E; Department of Medicinal Chemistry, Uppsala University, 752 37 Uppsala, Sweden.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634009 Tomsk, Russia., Tolmachev V; Department of Immunology, Genetics and Pathology, Uppsala University, 752 37 Uppsala, Sweden., Orlova A; Department of Medicinal Chemistry, Uppsala University, 752 37 Uppsala, Sweden.; Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden., Eriksson Karlström A; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, AlbaNova University Center, 106 91 Stockholm, Sweden.
Publikováno v:
ACS omega [ACS Omega] 2024 Aug 15; Vol. 9 (34), pp. 36122-36133. Date of Electronic Publication: 2024 Aug 15 (Print Publication: 2024).
Autor:
Zelchan R; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634055 Tomsk, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia., Chernov V; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634055 Tomsk, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia., Medvedeva A; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634055 Tomsk, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia., Rybina A; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634055 Tomsk, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia., Bragina O; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634055 Tomsk, Russia.; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia., Mishina E; Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634055 Tomsk, Russia., Larkina M; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.; Department of Pharmaceutical Analysis, Siberian State Medical University, 634050 Tomsk, Russia., Varvashenya R; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.; Department of Pharmaceutical Analysis, Siberian State Medical University, 634050 Tomsk, Russia., Fominykh A; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia., Schulga A; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia., Konovalova E; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia., Vorobyeva A; Department of Immunology, Genetics and Pathology, Uppsala University, 75185 Uppsala, Sweden., Orlova A; Department of Medicinal Chemistry, Uppsala University, 75185 Uppsala, Sweden., Tashireva L; Laboratory of Molecular Therapy of Cancer, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634055 Tomsk, Russia., Deyev SM; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia., Tolmachev V; Department of Immunology, Genetics and Pathology, Uppsala University, 75185 Uppsala, Sweden.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Aug 10; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 10.
Autor:
Zhang J; Department of Protein Science, KTH Royal Institute of Technology, Roslagstullsbacken 21, Stockholm 114 17, Sweden., Bodenko V; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia; Scientific and Educational Laboratory of Chemical and Pharmaceutical Research, Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk 634050, Russia., Larkina M; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk 634050, Russia., Bezverkhniaia E; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia; Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden., Xu T; Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden., Liao Y; Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden., Abouzayed A; Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden., Plotnikov E; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia., Tretyakova M; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia., Yuldasheva F; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia., Belousov MV; Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, Tomsk 634050, Russia; Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk 634050, Russia., Orlova A; Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden., Tolmachev V; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden., Gräslund T; Department of Protein Science, KTH Royal Institute of Technology, Roslagstullsbacken 21, Stockholm 114 17, Sweden. Electronic address: torbjorn@kth.se., Vorobyeva A; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden. Electronic address: anzhelika.vorobyeva@igp.uu.se.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Jun; Vol. 370, pp. 468-478. Date of Electronic Publication: 2024 May 08.
Autor:
Batle, J., Casas, M., Fortes, M., de Llano, M., Rojo, O., Sevilla, F. J., Solis, M. A., Tolmachev, V. V.
We review efforts to unify both the Bardeen, Cooper and Schrieffer (BCS) and Bose-Einstein condensation (BEC) pictures of superconductivity. We have finally achieved this in terms of a "\textit{complete} boson-fermion (BF) model" (CBFM) that reduces
Externí odkaz:
http://arxiv.org/abs/cond-mat/0211456
Publikováno v:
Physica C 364-365, 95 (2001).
Using the Bethe-Salpeter (BS) equation, Cooper pairing can be generalized to include contributions from holes as well as particles from the ground state of either an ideal Fermi gas (IFG) or of a BCS many-fermion state. The BCS model interfermion int
Externí odkaz:
http://arxiv.org/abs/cond-mat/0103398
Autor:
Tolmachev, V. A.1 (AUTHOR) tva@mail.ioffe.ru, Zharova, Yu. A.1 (AUTHOR), Grudinkin, S. A.1 (AUTHOR)
Publikováno v:
Optics & Spectroscopy. Dec2020, Vol. 128 Issue 12, p2002-2007. 6p.